{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"description":"Composite endpoint of GVH or infection. Too few events to compare between arms.","groups":[{"description":"Patients receiving umbilical cord blood for hematopoietic rescue following myeloablative conditioning.\n\n2/2 evaluable subjects engrafted at +45 and +90 days. 3 evaluable subjects for toxicity.","id":"OG000","title":"Myeloablative Conditioning"},{"description":"Patients receiving umbilical cord blood for hematopoietic rescue following non-myeloablative conditioning\n\n1/2 evaluable subjects engrafted at +45 and +90 days. 3 evaluable subjects for toxicity.","id":"OG001","title":"Reduced Intensity Conditioning"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"+180 days","title":"Compare Rates of Complications Between Patients Receiving Ablative vs. Non-myeloablative Conditioning Prior to UCB Transplantation","type":"SECONDARY","unitOfMeasure":"events"}